{"id":"W2946988148","doi":"10.1016/j.lungcan.2019.05.027","title":"Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer","year":2019,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Juravinski Cancer Centre; McMaster University; Vancouver Hospital and Health Sciences Centre; University of Toronto; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"Merck Canada; AstraZeneca Canada","keywords":"Durvalumab; Medicine; Oncology; Lung cancer; Pneumonitis; Internal medicine; Chemoradiotherapy; Context (archaeology); Clinical trial; Adverse effect; Cancer; Nivolumab; Immunotherapy; Lung","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005534149,0.0006605564,0.001750059,0.001380837,0.0001338447,0.0006689614,0.0006497004,0.0007023973,0.002927053],"category_scores_gemma":[0.0008557168,0.0002458076,0.0006937383,0.001645492,0.0002304371,0.0007109538,0.0004725674,0.001391013,0.0009132809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004986267,"about_ca_system_score_gemma":0.0008397312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001009253,"about_ca_topic_score_gemma":0.002938726,"domain_scores_codex":[0.9998648,0.00002702052,0.0000296311,0.00002427494,0.00003922388,0.00001495079],"domain_scores_gemma":[0.9997013,0.0001525409,0.00007821163,0.000006630772,0.00004469128,0.00001661763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001853664,0.00004952979,0.0001960797,0.02492254,0.0002542374,0.0000666296,0.0000254799,0.0003597118,0.0006301103,0.0007589741,0.02389594,0.9486554],"study_design_scores_gemma":[0.0002494605,0.0005380639,0.003040223,0.01795522,0.001842494,0.001177267,0.00005965666,0.0003072419,0.0006175984,0.001389929,0.9727886,0.00003423377],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006827567,0.9993919,0.00003226539,0.0001144608,0.00008855758,0.000002972054,0.00001173288,0.0000024026,0.0002874478],"genre_scores_gemma":[0.0008154247,0.9984117,0.0000736254,0.0002557801,0.0001235011,0.000006407893,0.00002503794,7.407926e-7,0.0002878741],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002927053,"threshold_uncertainty_score":0.00979203,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01980405145998392,"score_gpt":0.3242405323665668,"score_spread":0.3044364809065829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}